Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CVS Health Corp (CVS) vs Wendys Co (WEN) Price & Performance

CVS Health CorpTrade

Price performance (Past 24H)

Key statistics

CVS Health Corp vs Wendys Co — how do they compare? CVS Health Corp trades at $86.43 (market cap $112.49B), while Wendys Co trades at $6.21 (market cap $1.16B). The key difference: CVS Health Corp is far larger — about 97× Wendys Co's market cap, and Wendys Co pays the higher dividend (4.59%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Wendys Co for 77 Days on average.

CVSWEN
Market Cap
$112.49B$1.16B
Volume
8,467,3924,715,639
Sector
HealthConsumer Cyclical
52-Week High
$110.60$9.33
52-Week Low
$70.08$6.10
Typical Hold Time
83 Days77 Days
Enterprise Value
$174.83B$4.90B
Dividend Yield
3.02%4.59%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

CVS Health Corp

CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.

CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.

Wendys Co

Wendy's (WEN) trades at $6.22, up 0.97% today but remains under significant pressure with a bearish technical outlook. The stock shows attractive valuation metrics including a P/E of 9.25 and P/S of 0.53, though fundamentals reveal declining profitability with net income margin dropping to 5.72% in 2025. Recent news highlights challenges including a major franchisee bankruptcy filing and six consecutive quarters of same-store sales declines, creating headwinds for the burger chain.

Despite low valuations and consistent earnings beats, Wendy's faces substantial operational challenges including franchisee instability and competitive pressures. The consensus price target of $7.58 suggests 22% upside potential, but investor sentiment remains cautious given the deteriorating fundamentals and bearish technical signals. Recovery depends on successful execution under new CEO Bob Wright and reversing negative sales trends.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CVS

No sentiment data available yet.

WEN
85% Buy15% Sell
Avg holding period · 77 Days

Top news

Latest headlines on both assets

About CVS Health Corp

Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.

Read more on CVS →

About Wendys Co

The Wendy's Company is the second-largest burger quick-service restaurant, or QSR, chain in the United States by systemwide sales, with $11.1 billion in 2021, narrowly edging Burger King ($10.3 billion) and clocking in well behind wide-moat McDonald's ($45.7 billion). After divestitures of Tim Hortons (2006) and Arby's (2011), the firm manages just the burger banner, generating sales across a footprint that spans almost 7,000 total units in 30 countries. Wendy's generates revenue from the sale of hamburgers, chicken sandwiches, salads, and fries throughout its company-owned footprint, through franchise royalty and marketing fund payments remitted by its franchisees, which account for 94% of stores, and through franchise flipping and advisory fees.

Read more on WEN →